US · guidance
CMS Pub. 100-04, ch. 4, § 320
Outpatient Intravenous Insulin Treatment (OIVIT)
Effective for claims with dates of service on and after December 23, 2009, the Centers
for Medicare and Medicaid Services (CMS) determines that the evidence does not
support a conclusion that OIVIT improves health outcomes in Medicare beneficiaries.
Therefore, CMS has determined that OIVIT is not reasonable and necessary for any
indication under section 1862(a)(1)(A) of the Social Security Act. Services comprising
an OIVIT regimen are nationally non-covered under Medicare when furnished pursuant
to an OIVIT regimen.
See Pub. 100-03, Medicare National Coverage Determinations Manual, Section 40.7,
Outpatient Intravenous Insulin Treatment (Effective December 23, 2009), for general
information and coverage indications.
History
(Rev. 1930, Issued: 03-09-10, Effective Date: 12-23-09; Implementation Date: 04- 05-10)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
6ed1d778fbf1d076252011a82ff59425acd8e2bc6c7deeaf39cecd178f4a996e
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.